Bioactive Compounds and Antitumor Agents
Bioactive Compounds and Antitumor Agents is a research topic within Toxicology. Science Explorer counts 25k research works in it since 1950. 15.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the role of quinones in toxicology and pharmacology, focusing on their cytotoxic effects, NAD(P)H:Quinone Oxidoreductase activity, apoptosis induction, and potential as anticancer and antimicrobial agents. The papers cover a wide range of topics including cellular pharmacology studies, mechanisms of cytotoxic action, pharmacological properties, and the synthesis and evaluation of quinone derivatives.
- Quinones
- Toxicology
- Pharmacology
- Cytotoxicity
- NAD(P)H:Quinone Oxidoreductase
- Apoptosis
- Anticancer Agents
- Reactive Oxygen Species
- Antimicrobial Activity
- Cell Signaling
- Research works
- 25k fractional, since 1950
- In the world top 10%
- 3.9k per year above
- Top-10% rate
- 15.8% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- 0% the tick is no change
Which countries lead Bioactive Compounds and Antitumor Agents research?
By volume, China and India publish the most (685 and 506 works in 2022–2025).
By volume, 2022–2025
- 1 China 685 works
- 2 India 506 works
- 3 United States 188 works
- 4 Türkiye 115 works
- 5 Brazil 112 works
- 6 Egypt 112 works
- 7 Saudi Arabia 97 works
- 8 South Korea 88 works
- 9 Iran 87 works
- 10 Russia 82 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Bioactive Compounds and Antitumor Agents research?
By volume in 2022–2025, King Saud University publishes the most Bioactive Compounds and Antitumor Agents research, followed by Cairo University and Academy of Scientific and Innovative Research.
By volume, 2022–2025
- 1 King Saud UniversitySaudi Arabia 20 works
- 2 Cairo UniversityEgypt 15 works
- 3 Academy of Scientific and Innovative ResearchIndia 13 works
- 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 12 works
- 5 Saveetha UniversityIndia 11 works
- 6 Chinese Academy of SciencesChina 11 works
- 7 National Research CentreEgypt 10 works
- 8 China Pharmaceutical UniversityChina 9 works
- 9 Sichuan UniversityChina 9 works
- 10 Al-Azhar UniversityEgypt 9 works
Who are the leading researchers in Bioactive Compounds and Antitumor Agents?
The most-cited researchers publishing on Bioactive Compounds and Antitumor Agents include Peter A. Kollman, Bharat B. Aggarwal and Peter G. Jones.
- 1 Peter A. Kollman United States 6.3k citations
- 2 Bharat B. Aggarwal United States 4.2k citations
- 3 Peter G. Jones Germany 3.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Bioactive Compounds and Antitumor Agents research done?
The largest centres of Bioactive Compounds and Antitumor Agents research in 2022–2025 are Beijing (China), Shanghai (China), Riyadh (Saudi Arabia) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Giza.
Largest cities, 2022–2025
Where it is the local speciality
- GizaEG · 26.6 works5.9×
Location quotient: how much more of its research is in Bioactive Compounds and Antitumor Agents than the world average.
Where is the best place to study Bioactive Compounds and Antitumor Agents?
Among universities, judged by research, Al-Azhar University, King Saud University and Cairo University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Al-Azhar UniversityEgypt | 58.3 | 52.3% | 7.6× | 9 | +35.4% |
| 2 | King Saud UniversitySaudi Arabia | 53.5 | 21.4% | 7.3× | 20 | +9.4% |
| 3 | Cairo UniversityEgypt | 50.4 | 35.1% | 6.5× | 15 | +18.2% |
| 4 | Academy of Scientific and Innovative ResearchIndia | 49.4 | 17.4% | 13.4× | 13 | +350.7% |
| 5 | China Pharmaceutical UniversityChina | 36.0 | 24.9% | 14.4× | 9 | +19.3% |
| 6 | Saveetha UniversityIndia | 26.8 | 24.3% | 3.7× | 11 | — |
| 7 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 25.7 | 23.3% | 4.2× | 12 | +17.4% |
| 8 | Sichuan UniversityChina | 5.4 | 20.5% | 1.8× | 9 | -32.6% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Bioactive Compounds and Antitumor Agents research growing?
Output in 2018–2022 was 0% lower than in 2013–2017, peaking in 2024. The fastest-growing topics are Bioactive Compounds and Antitumor Agents.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.